Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$13.70M
Expense Ratio	0.80%
PE Ratio	24.28
Shares Out	350,000
Dividend (ttm)	$0.12
Dividend Yield	0.32%
Ex-Dividend Date	Dec 31, 2025
Payout Frequency	Annual
Payout Ratio	7.71%

Volume	1,121
Open	39.31
Previous Close	39.32
Day's Range	39.05 - 39.31
52-Week Low	31.08
52-Week High	41.52
Beta	1.03
Holdings	26
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

65.03% of assets

Name	Symbol	Weight
Veradermics, Incorporated	MANE	7.89%
Antero Resources Corporation	AR	7.07%
Golar LNG Limited	GLNG	7.06%
Modine Manufacturing Company	MOD	6.47%
Perdoceo Education Corporation	PRDO	6.46%
Public Policy Holding Co Inc Ordinary Shares	PPHC.L	6.24%
Rush Street Interactive, Inc.	RSI	6.11%
The Southern Company	SO	6.02%
Motorola Solutions, Inc.	MSI	5.87%
Sandisk Corporation	SNDK	5.84%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 31, 2025	$0.1249	Jan 2, 2026
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 6.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.62%.